JPRN-UMIN000018758已完成未知
The additional biomarker study and clinical outcome of Phase II study of Neoadjuvant Eribulin followed by FEC for operable triple-negative breast cancer. - The additional study of a phase II study of Neoadjuvant Eribulin in TNBC patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patient considered irrelevant by attending physician for the study
研究者
相似试验
进行中（未招募）
1 期
A non-blinded retrospective biomarker add-on study to FIGARO-DKD for Bioprofiling the pharMacodynamic response to finerenone in FIGARO-DKD subjects (FIGARO-BM)Type II Diabetes Mellitus and Diabetic Kidney DiseaseMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2021-003053-37-BGBayer AG600
进行中（未招募）
1 期
A non-blinded retrospective biomarker add-on study to FIGARO-DKD for Bioprofiling the pharMacodynamic response to finerenone in FIGARO-DKD subjects (FIGARO-BM)Type II Diabetes Mellitus and Diabetic Kidney DiseaseMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2021-003053-37-ESBayer AG600
尚未招募
不适用
Exploratory study of biomarker for complications as thrombosis after portal vein embolizatioPatient underwent portal vein embolizationJPRN-UMIN000014075Yokohama City University Graduate School of Medicine60
已完成
不适用
Study on biomarkers for the effect and safety of the treatment with Atezolizumab + Bevacizumab for liver cancerunresectable advanced hepatocellular carcinomaJPRN-UMIN000047758agoya University Graduate School of Medicine99
尚未招募
不适用
Biomarker study for postoperative AKI of Emergency surgeryAcute abdomenJPRN-UMIN000037653St marianna University School of Medicine150